Serum concentration–guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience

Delayed cerebral infarction (DCI) is a major cause of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). The benefits of magnesium sulfate as an alternative treatment are controversial, and most previous studies examined its benefits only as adjunctive treatment to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wipplinger, C., Cattaneo, A., Wipplinger, T. M., Lamllari, K., Semmler, F., Geske, C., Messinger, J., Nickl, V., Beez, A., Ernestus, R.-I., Pham, M., Westermaier, T., Weiland, J., Stetter, C., Kunze, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522732/
https://www.ncbi.nlm.nih.gov/pubmed/37751032
http://dx.doi.org/10.1007/s10143-023-02159-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522732/
https://www.ncbi.nlm.nih.gov/pubmed/37751032
http://dx.doi.org/10.1007/s10143-023-02159-1

Ejemplares similares